[Purpose] The purpose of the present study was to investigate somatosensory cortical reorganization in terms of source locations of somatosensory evoked magnetic fields (SEFs) in hemiplegic patients after thalamic hemorrhage. [Subjects] Nine hemiplegic patients after thalamic hemorrhage participated in this study.
INTRODUCTION
Somatosensory cortical reorganization (SCR) is associated with sensory impairments and their recoveries 1) . Since thalamic hemorrhage impairs not only the thalamus but also the internal capsule, patients after thalamic hemorrhage exhibit sensory (and motor) impairments. However, little is known about SCR in the patients.
Magnetoencephalography (MEG) has been widely applied to modern clinical neurological studies. MEG, which measures the magnetic fields generated by neuronal electrical activities, provides a non-invasive evaluation method of cerebral functions, and its high spatial resolution enables cerebral cortical mapping 2) . We have reported that findings of somatosensory evoked magnetic fields (SEFs) could contribute to the early outcome prediction on sensorimotor functions in hemiplegic patients after thalamic hemorrhage 3) , but have not investigated SCR in such patients.
The purpose of the present study was to investigate SCR in hemiplegic patients after thalamic hemorrhage in terms of SEF source locations.
SUBJECTS
Nine hemiplegic patients after thalamic hemorrhage, who received conservative treatments for thalamic hemorrhage, participated in this study. Patients were excluded if they could not understand simple orders due to higher cortical dysfunctions. Written informed consent was obtained from all the patients. Their demographic profiles are presented in Table 1 .
METHODS
SEFs were measured using a 204 channel wholehead MEG system (Neuromag, Helsinki, Finland) in a magnetically shielded room within 72 hours (acute stage) and at three months (chronic stage) after the onset of thalamic hemorrhage. SEF measurement was performed with the patient awake and reclining on a bed with the head inserted into the MEG helmet. In this study, SEFs in the affected and healthy hemispheres were obtained with alternative current stimulation on the left and right median nerves at the wrist. The stimulus current was monophasic square-wave impulses with 0.3 ms duration at 2.8 Hz. The stimulus intensity was just above the motor threshold of the abductor pollicis brevis muscle. The conditions for the SEFs data acquisition were sampling at 1000 Hz and bandpass filtering between 0.1 to 265 Hz. The SEF data were averaged 200 times for further analysis.
In SEF analysis, according to a procedure described by Wikstrom et al. 4) , source estimation using a single equivalent current dipole (ECD) model 5) was performed to two median nerve SEF c o m p o n e n t s i n t h e a f f e c t e d a n d h e a l t h y hemispheres. The first component is an anteriororiented ECD with the peak latency of about 20 ms post-stimulus (i.e. N20m 2) ). The second is a posterior-oriented ECD with the shortest peak latency among the components observed within 91 ms post-stimulus after the first component. The former and latter components, which are considered to originate from the primary somatosensory c or t e x 4 ) , w ere de signa t ed N1m a nd P1m, respectively. Before the SEF analysis, a threedimensional cartesian coordinate was made on a workstation using fiduciary points, i.e. the nasion and bilateral preauricular points, on the patient's head, and each estimated SEF source was expressed as a point in this coordinate system. The axes of the coordinates were defined as follows: the x-axis (medio-lateral direction) through the bilateral preauricular points, outgoing leftward, the y-axis (anterior-posterior direction) through the nasion, crossing at right angles to the x-axis and outgoing forward, and the z-axis (cranio-caudal direction) crossing at right angles to the x-and y-axes and outgoing upward. The source location change of each median nerve SEF component between the 4) , which was established in healthy subjects, it was judged that the source location of the median nerve SEF component had significantly changed between the acute and chronic stages. The SEF measurement and analysis were performed by a physical therapist (H.Y.) supervised by a physiatrist (T.K.) and neurosurgeon (N.N.). Assessment of affected UE impairments, i.e. sensory disturbance, motor palsies, and activities of daily living (ADLs), were performed at the acute stage, one month after the onset of thalamic hemorrhage (subacute stage) and the chronic stage. The sensory disturbance was assessed using the thumb localizing test 6) , which classifies the severities of the joint position sensation of the affected UE into sequential four grades: "normal", "slightly impaired", "severely impaired" and "sensory loss". The details of the classification are described elsewhere 3) . The motor palsies were assessed using Brunnstrom's motor recovery stage (BS) 7) for the UE and fingers. ADLs were assessed using the Barthel Index (BI) 8) .
All the patients received UE rehabilitation treatment aimed at achieving active use of the affected UE. In the treatment, various tasks which required use of patient's bilateral UEs and only the affected UE were utilized. However, use of their non-affected UEs in ADLs was not limited at all. All the patients received the treatment one hour a day, five times a week. Table 1 presents the clinical profiles of affected UE impairments and ADLs of our patients. The majority of patients 1~7 showed severe affected UE impairments and ADLs at the acute stage. Among them, patients 4~6 demonstrated good recovery of ADLs (BI: 90~95) as well as sensory disturbance ("normal") and motor palsies (BS: V) at the subacute stage. In contrast, patients 1~3 and 7 showed poor motor recoveries (BS: IV or less) even at the chronic stage as opposed to the good sensory recoveries ("slightly impaired" or "normal", except patient 3) at the chronic stage. Additionally, they showed relatively slow ADL recoveries (BI: 40~75 at the subacute stage, 75~80 at the chronic stage) compared with patients 4~6 (BI: 90~95 at the subacute stage, 95~100 at the chronic stage). Patients 8 and 9, who showed the "normal" sensory hemisphere, all the patients showed both N1m and P1m at the acute and chronic stages. In the affected hemisphere, patients 1~3 showed neither N1m nor P1m at the acute stage, and therefore it was impossible to investigate their source location changes between the acute and chronic stages in the patients. Patients 4~9 showed N1m and/or P1m at the acute and chronic stages. However, two (patients 5 and 6) of them did not show N1m at the acute stage, and therefore it was impossible to investigate its source location change between the acute and chronic stages. In the affected hemisphere, no patients showed significant N1m and P1m source location changes between the acute and chronic stages. In the healthy hemisphere, to the contrary, three patients showed significant N1m (patient 5) or P1m (patients 1 and 9) source location changes between the acute and chronic stages. The Figure 1 demonstrates anatomical images of the N1m and P1m sources showing the significant source location changes between the acute and chronic stages.
RESULTS
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DISCUSSION
In the present study, significant N1m or P1m source location changes in the healthy hemisphere between the acute and chronic stages were observed in patients 1, 5, and 9, although they were not observed in the previous study using the same analysis method of N1m and P1m source location changes 4) . The significant N1m and P1m source location changes in the healthy hemisphere between the acute and chronic stages observed in our patients may be related to a feature of ADLs in hemiplegic patients. Hemiplegic patients often depend on the non-affected UE in ADLs even if affected UE impairments are slight 9) . Although our patients used their affected UEs actively in the rehabilitation treatment, they would depend on the non-affected UE in ADLs, because use of their nonaffected UEs in ADLs was not limited at all. Additionally, an increase in use of a body part induces an enlargement of the sensorimotor cortices r e l a t e d t o t h e b o d y p a r t ( u s e -d e p e n d e n t plasticity 10) ). Since hemiplegic patients are dependent on the non-affected UE, they must use their non-affected UEs actively in ADLs, and the significant N1m and P1m source location changes in the healthy hemisphere between the acute and chronic stages observed in our patients might reflect SCR based on use-dependent plasticity. However, this interpretation has at least two weaknesses. The first weakness is that the patients showing significant N1m or P1m source location changes in the healthy hemisphere between the acute and chronic stages were only a subset of the patients possibly dependent on the non-affected UE in ADLs. Although there were no great differences in the clinical profiles between the patients showing significant N1m or P1m source location changes in the healthy hemisphere and those not showing them, both the former and latter patients had various affected UE impairments from the acute to chronic stages. Therefore, the majority of our patients were possibly dependent on the non-affected UE in ADLs 9) . A possible explanation of this is the difference of the amount of use of the non-affected UE in ADLs among them. Unfortunately, we cannot verify this explanation scientifically because we did not investigate the amount of use of the nonaffected UE in ADLs of each patient. Subsequent studies should investigate the relationship between the amount of use of the non-affected UE in hemiplegic patients after thalamic hemorrhage and N1m and P1m source location changes in the healthy hemisphere. The second weakness is that there were no patients showing both significant N1m and P1m source location changes. If SCR occurs, both significant N1m and P1m source location changes should be observed, because N1m and P1m are considered to originate from the primary somatosensory cortex 4) . In future studies, additional experiments using other cortical mapping techniques should be planned to verify SCR suggested by either significant N1m or P1m source location changes.
In contrast to the previous study 4) which reported that some patients showed significant N1m or P1m source location changes in the affected hemisphere, interpreted as having resulted from displacements of cortical structures caused by cerebral edema after infarction, not SCR, we observed neither significant N1m nor P1m source location changes in the affected hemisphere between the acute and chronic stages in patients 4~9, the only patients for whom it was possible to investigate N1m and/or P1m source location changes in the affected hemisphere between the acute and chronic stages. When paying attention to the sensory recoveries of the affected UE of these patients, all of them showed good recoveries at the subacute stage. The absence of severe damage of the neural structures related to sensory function (e.g. the dorsal column-medial lemniscal tract) permits stroke patients to regain function early after the onset 3, 11) . Therefore, patients 4~9 had only slight damage of the neural structures, and plasticity in their affected hemispheres would be not so important for sensory recoveries of their affected UEs. This is a possible reason why they showed neither significant N1m nor P1m source location changes in the affected hemisphere between the acute and chronic stages.
In patients 1~3, on the other hand, it was impossible to investigate both N1m and P1m source location changes in the affected hemisphere between the acute and chronic stages because they showed neither N1m nor P1m in the affected hemisphere at t h e a c u t e s t a g e . T h e f i n d i n g s t h a t t h e y demonstrated slow and poor sensory recoveries of the affected UE compared with patients 4~9 suggest that they had relatively severe damage of the neural structures, and we should not deny the possibility that SCR in their affected hemispheres occurred. In such patients, using cortical mapping techniques other than MEG will be needed to investigate SCR in the affected hemisphere.
